Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial
Article in BMJ Open (April 2024)
The most recent citing publications are shown below. View all 204 publications that cite this research output on Dimensions.
Article in BMJ Open (April 2024)
Article in Journal of Clinical Medicine (April 2024)
Article in Journal of Pharmacology and Experimental Therapeutics (April 2024)